Leukemia

Proteinuria Higher With Dasatinib Exposure in Chronic Myelogenous Leukemia

Publish Date September 26, 2023

Urine albumin-creatinine ratio significantly higher for patients receiving dasatinib.

Vitamins C, D Supplementation Beneficial in Chemotherapy for Acute Myeloid Leukemia

By

Jennifer Larson

Publish Date September 22, 2023

Use of vitamin C and D supplementation evaluated for its efficacy for patients with AML undergoing intensive induction chemotherapy.

Homoharringtonine-Based Induction Therapy May Reduce Post-Transplant Relapse in Pediatric AML

By

Lauren Dembeck, PhD

Publish Date August 11, 2023

Researchers sought to determine whether homoharringtonine-based induction therapy would lower disease recurrence in pediatric patients with AML after HSCT.

Adding Venetoclax to FLA-IDA Improves Overall Response Rate, But Not Other Measures in AML

By

Jonathan Goodman, MPhil

Publish Date August 8, 2023

Researcher sought to determine whether adding venetoclax to FLA-IDA would improve responses in patients with relapsed or refractory AML.

Maintenance Sorafenib Improves Long-Term Survival Post-HSCT in AML Subgroup

By

Jonathan Goodman, MPhil

Publish Date August 4, 2023

Researchers sought to determine whether sorafenib maintenance would improve survival in patients with AML with FLT3-ITD undergoing HSCT.

Leukemia Clinical Trials

Clinical Trial: Molecular Epidemiology of Childhood Leukemia (Aka The California Childhood Leukemia Study) (CCLS)

Clinical trial focusing on the molecular epidemiology of childhood leukemia. Molecular Epidemiology of Childhood Leukemia (Aka The California Childhood Leukemia Study) (CCLS)

Clinical Trial: Genetic Study of Chronic Lymphocytic Leukemia Families

Clinical trial focusing on genetics and chronic lymphocytic leukemia. Genetic Study of Chronic Lymphocytic Leukemia Families

Clinical Trial: Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation

Clinical trial focusing on vaccine generation from chronic lymphocytic leukemia tumor cells. Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation

Clinical Trial: Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia

Clinical trial focusing on GNKG168. Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia

Clinical Trial: Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL)

Clinical trial focusing on carfilzomib Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL). Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL) .